GSK Asks Senate To Rethink Patent Reform Act

Law360 (January 19, 2008, 12:00 AM EST) -- The chief executive of pharmaceutical giant GlaxoSmithKline Plc has urged senators to rethink a key provision of the Patent Reform Act, according to a letter acquired by the PLI patent blog.

In the letter obtained by patent attorney Gene Quinn, editor and lead contributor to the blog, GSK objected to a section of the Senate bill that would require patent applicants to submit an exhaustive search report, including a patentability analysis and a search of prior art.

That provision, the letter said, puts no bounds on...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.